Apreo Health Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$130M
- Investors
-
9
Apreo Health General Information
Description
Developer of an airway scaffold designed to restore health and quality of life to patients with severe emphysema. The company's technology utilizes a self-expanding nitinol scaffold and bronchoscopy delivery systems, enabling healthcare providers to release trapped air and reduce lung hyperinflation through a tissue-sparing approach.
Contact Information
Website
www.apreohealth.comCorporate Office
- 4040 Campbell Avenue
- Suite 210
- Menlo Park, CA 94025
- United States
Corporate Office
- 4040 Campbell Avenue
- Suite 210
- Menlo Park, CA 94025
- United States
Apreo Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 13-May-2025 | $130M | Completed | Clinical Trials - Phase 3 | ||
| 1. Early Stage VC (Series A) | 28-Jan-2022 | Completed | Clinical Trials - Phase 3 |
Apreo Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-3 | ||||||||
| Series B-2B | ||||||||
| Series B-2A | ||||||||
| Series B-1 | 121,221,915 | $0.001000 | 8% | $0.62 | $0.62 | 1x | $0.62 | 40.57% |
| Series A | 22,431,298 | $0.001000 | 8% | $1.05 | $1.05 | 1x | $1.05 | 7.57% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Apreo Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Apreo Health Patents
Apreo Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026011164-A1 | Methods and systems for planning, predicting, and monitoring therapies for pulmonary diseases | Pending | 03-Jul-2024 | ||
| EP-4654928-A1 | Devices, systems, and methods for treating airway collapse | Pending | 25-Jan-2023 | ||
| US-20260053648-A1 | Devices, systems, and methods for treating airway collapse | Pending | 25-Jan-2023 | ||
| WO-2024159056-A1 | Devices, systems, and methods for treating airway collapse | Inactive | 25-Jan-2023 | ||
| EP-4654930-A2 | Methods and systems for treating pulmonary disease | Pending | 25-Jan-2023 | A61F2/04 |
Apreo Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Apreo Health Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bain Capital Life Sciences | Corporate Venture Capital | Minority | ||
| F-Prime | Venture Capital | Minority | ||
| Intuitive Ventures | Corporate Venture Capital | Minority | ||
| Norwest | Venture Capital | Minority | ||
| OSF Healthcare | Corporation | Minority |
Apreo Health FAQs
-
When was Apreo Health founded?
Apreo Health was founded in 2021.
-
Where is Apreo Health headquartered?
Apreo Health is headquartered in Menlo Park, CA.
-
What is the size of Apreo Health?
Apreo Health has 35 total employees.
-
What industry is Apreo Health in?
Apreo Health’s primary industry is Therapeutic Devices.
-
Is Apreo Health a private or public company?
Apreo Health is a Private company.
-
What is the current valuation of Apreo Health?
The current valuation of Apreo Health is .
-
What is Apreo Health’s current revenue?
The current revenue for Apreo Health is .
-
How much funding has Apreo Health raised over time?
Apreo Health has raised $154M.
-
Who are Apreo Health’s investors?
Bain Capital Life Sciences, F-Prime, Intuitive Ventures, Norwest, and OSF Healthcare are 5 of 9 investors who have invested in Apreo Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
